argenx SE (ARGX)
Company Info
Highlights
$39.67B
$12.80
50.76
$2.72B
$1.51B
$96.13M
$352.77 - $678.21
$771.92
4.13%
5.08
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in argenx SE, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
argenx SE (ARGX) returned -7.46% year-to-date (YTD) and 47.41% over the past 12 months.
ARGX
-7.46%
3.68%
-3.77%
47.41%
30.84%
N/A
^GSPC (Benchmark)
-3.70%
13.67%
-5.18%
9.18%
14.14%
10.43%
Monthly Returns
The table below presents the monthly returns of ARGX, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 6.53% | -4.65% | -5.25% | 9.00% | -11.78% | -7.46% | |||||||
| 2024 | 0.02% | -0.13% | 3.61% | -4.63% | -1.19% | 15.91% | 19.96% | 0.28% | 4.79% | 8.16% | 5.16% | -0.25% | 61.66% |
| 2023 | 0.90% | -4.25% | 1.79% | 4.11% | 0.21% | 0.26% | 29.44% | -0.39% | -2.16% | -4.49% | -4.04% | -15.57% | 0.42% |
| 2022 | -23.11% | 6.85% | 9.59% | -8.88% | 7.65% | 22.50% | -3.87% | 3.75% | -6.57% | 9.88% | 2.59% | -4.81% | 8.18% |
| 2021 | -0.36% | 12.85% | -16.72% | 4.11% | -2.69% | 7.91% | 1.12% | 8.73% | -8.77% | -0.01% | -7.53% | 25.42% | 19.08% |
| 2020 | -10.11% | -2.02% | -6.83% | 11.20% | 49.70% | 2.70% | 2.18% | 0.50% | 13.51% | -5.48% | 15.59% | 2.53% | 83.21% |
| 2019 | 10.45% | 25.61% | -6.34% | 2.59% | -3.47% | 14.52% | -0.79% | -6.41% | -13.31% | 7.46% | 20.90% | 8.42% | 67.09% |
| 2018 | 22.87% | -1.22% | 4.97% | 8.93% | 8.99% | -13.24% | 9.52% | 3.39% | -19.17% | 5.50% | 20.95% | -0.72% | 52.15% |
| 2017 | -9.35% | 1.73% | -1.13% | -0.33% | 8.18% | 1.37% | 39.70% | 97.19% | 174.52% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
With an overall rank of 87, ARGX is among the top 13% of stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for argenx SE (ARGX) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the argenx SE. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the argenx SE was 38.20%, occurring on Dec 20, 2023. Recovery took 177 trading sessions.
The current argenx SE drawdown is 15.28%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -38.2% | Jul 24, 2023 | 106 | Dec 20, 2023 | 177 | Sep 5, 2024 | 283 |
| -36.29% | Jun 13, 2018 | 84 | Oct 10, 2018 | 19 | Nov 6, 2018 | 103 |
| -34.13% | Jan 10, 2020 | 45 | Mar 16, 2020 | 49 | May 26, 2020 | 94 |
| -33.09% | Feb 12, 2021 | 242 | Jan 27, 2022 | 108 | Jul 5, 2022 | 350 |
| -29.18% | Jul 19, 2019 | 57 | Oct 8, 2019 | 40 | Dec 4, 2019 | 97 |
Volatility
Volatility Chart
The current argenx SE volatility is 15.58%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
The chart below illustrates the trends in the financial health of argenx SE over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Earnings Per Share
The chart presents the Earnings Per Share (EPS) performance of argenx SE, comparing actual results with analytics estimates. In the past quarter, the company did not meet analyst expectations for EPS, resulting in a surprise of -58.0%.
Valuation
The Valuation section provides an overview of how argenx SE is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for ARGX, comparing it with other companies in the Biotechnology industry. Currently, ARGX has a P/E ratio of 50.8. This P/E ratio is significantly higher than those of industry peers. This could indicate that the stock is overvalued or that investors expect strong future growth.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for ARGX compared to other companies in the Biotechnology industry. ARGX currently has a PEG ratio of 0.0. This PEG ratio is low compared to industry peers, which could indicate the stock is undervalued relative to its expected growth.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for ARGX relative to other companies in the Biotechnology industry. Currently, ARGX has a P/S ratio of 17.6. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for ARGX in comparison with other companies in the Biotechnology industry. Currently, ARGX has a P/B value of 7.2. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |